Abstract
Objectives: It is currently debated whether patients with residual viraemia are at higher risk of virological failure than those attaining 50 copies/mL after baseline, and the time to virological rebound was calculated using the Kaplan-Meier method. Results: There were 739 eligible patients; 446 (60.4%) had HIV RNA 3 per year versus +21.2 (22.5, 53.2)cells/mm3 per year; P1/40.036. Conclusions: Residual viraemia assessed by kPCR was not associated with virological rebound during 1 year of follow-up. However, the patients attaining
Original language | English |
---|---|
Pages (from-to) | 213-217 |
Number of pages | 5 |
Journal | Journal of Antimicrobial Chemotherapy |
Volume | 67 |
Issue number | 1 |
DOIs | |
Publication status | Published - 2012 |
Keywords
- Antiretroviral therapy
- HIV-1 viral load
- Immune recovery
- kPCR
- Virological failure
ASJC Scopus subject areas
- Pharmacology
- Pharmacology (medical)
- Infectious Diseases
- Medicine(all)